Extracorporeal shock wave therapy (ESWT), a new treatment method, is a new technology combining physics and medicine, which is known as a green therapy for orthopedic diseases because of its basic lack of side effects. The extracorporeal shock wave therapy uses shock waves to produce a series of biological effects on human internal tissues and cells, such as mechanical pressure effect, piezoelectric effect, cavitation effect, pain relief effect, etc. to activate osteoblasts, promote the formation of new blood vessels and cell repair and regeneration, reduce chronic inflammation, relieve pain and other effects, while not causing damage to the human body, which belongs to the category of minimally invasive treatment. The technique has many advantages over traditional surgical treatment, such as non-invasive, simple method, significant efficacy, low risk, short treatment period, few complications, and relatively low cost. In Germany, Switzerland, Austria and the United Kingdom have approved the technology for clinical use, the U.S. Food and Drug Administration (FDA) in 2000 and 2002 respectively approved shock wave therapy machine for clinical treatment of plantar fasciitis and tennis elbow, etc., China’s State Drug Administration (SDA) also approved in 2002 for clinical treatment of bone tissue and muscular system diseases, for athletes training strain injury. The National Sports Center also routinely carries out shock wave therapy. The main treatment items include: 1. Tendon and fascia disorders: including frozen shoulder, humerus internal/external epicondylitis (tennis elbow/golf elbow), tendonitis, bursitis, patellar tendonitis, Achilles tendon tendon sheath, plantar fasciitis and calcific tendonitis, etc. 2. Bone and osteochondral disorders: including fracture non-union/delayed healing, post-fracture pseudoarthrosis, heel spur, femoral epiphyseal osteochondrosis, Osgood Schlatter disease (tibial tuberosity osteochondrosis) and Kohler disease (aseptic necrosis of the navicular bone), etc.